Changes in outcomes over time. by Jae-Heung Cho (798319)

“…Despite no significant differences in pain reduction at week 5, CMT was found to be a cost-effective treatment for TMD, particularly for improving function and quality of life. …”

Study timetable. by Jae-Heung Cho (798319)

“…Despite no significant differences in pain reduction at week 5, CMT was found to be a cost-effective treatment for TMD, particularly for improving function and quality of life. …”

Cumulative incidence curves of recovery by group. by Jae-Heung Cho (798319)

“…Despite no significant differences in pain reduction at week 5, CMT was found to be a cost-effective treatment for TMD, particularly for improving function and quality of life. …”

Experiment 2: Model-free analysis of effort discounting. by Miriam C. Klein-Flügge (713481)

“…(default magnitude—(indifferent magnitude—default magnitude)) (bottom). A multiplicative representation yields a percentage decrease, whereas an additive representation reflects the absolute decrease in value, which can easily lead to negative values. …”

ELISA Inhibition results using rMal d 3 and rPru p 3 in the solid phase for a representative case from Group 1 with GS (A); Mal d 4 and Pho d 2 in a representative case from Group... by Francisca Gomez (628386)

Decreased severity of CIA following adoptive transfer of CD4+CD25+ T cells induced by the CII pulsed T/C-DC treatment. by Franco Carranza (149412)

Infection with <i>Salmonella</i> leads to decreased proportions of CD4⁺ and CD8⁺ T lymphocytes in the spleen. by Kristin L. Rosche (754117)

Bacterial load in lung and spleen of binge-drinking mice intranasally infected with decreasing doses of <i>B</i>. <i>thailandensis</i>. by Victor M. Jimenez Jr. (8107853)

Antioxidation and Anti-Inflammatory Activity of Prussian Blue Nanozymes to Alleviate Acetaminophen-Induced Acute Liver Injury by Qiang Feng (88137)

“…The mechanism of liver injury induced by APAP is mainly related to oxidative stress and inflammatory reaction. Herein, we report a simple and efficient one-step synthesis of Prussian blue (PB) nanozymes with multiple antioxidant enzymatic activities that effectively treat APAP-induced DILI. …”

Inhibition of survivin decreased the expression of HIF-1α, TGF-β1 and TFE3 in human SACC-83 cell line. by Yu-Fan Wang (671665)

Neutralization with Anti-sialidase Serum Decreases <i>P. acnes</i>-induced Cell Death and IL-8 Production in Human Sebocytes. by Teruaki Nakatsuji (39298)

Effect of the 5′ terminal stem–loop structure on the affinity of the 5′-UTR for Hfq and ribosomes by Taras Afonyushkin (8816)

“…All rights reserved</p> () 5′ end-labelled and RNAs were incubated alone (lanes 1 and 6) or with increasing amounts (2-, 4-, 6- and 8-fold molar excess) of Hfq-hexamer (lanes 2–5 and 7–10, respectively), and the resulting mixtures were then analysed on a 6% native gel. …”

Mefloquine treatment decreases cochlear outer and inner hair cell survival, while NAD⁺ treatment protects the hair cells. by Dalian Ding (385461)

Table_3_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

“…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”

Table_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

“…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”

Image_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

“…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”

Image_4_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

“…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”

Table_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

“…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”

Image_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

“…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”

Image_3_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

“…Through the isolation and characterization of monoclonal antibodies (mAbs) from individuals infected with SARS-CoV-2, we identified one antibody, P36-5D2, capable of neutralizing the major SARS-CoV-2 variants of concern. …”